1)Sugano K, Osawa H, Satoh K, et al:Clinical management of helicobacter pylori:the Japanese perspective. Dig Dis 32:281-289, 2014
2)日本消化器病学会(編);消化性潰瘍診療ガイドライン2020,改訂第3版.南江堂,2020,pp 174-183
3)飯島克則:Helicobacter pylori感染陰性時代の消化管疾患:胃・十二指腸潰瘍はどう変わる.日内会誌106:33-38,2017
4)菅野 武,小池智幸,正宗 淳:特発性潰瘍:注目すべき非H. pylori非NSAIDsの胃・十二指腸潰瘍.新薬と臨69:873-877,2020
5)Kanno T, Iijima K, Abe Y, et al:A multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan. J Gastroenterol Hepatol 30:842-848, 2015
6)Asaka M, Kato M, Sugiyama T, et al:Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroentero 38:339-347, 2003
7)Miwa H, Sakaki N, Sugano K, et al:Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication:a multicenter study of 4940 patients. Helicobacter 9:9-16, 2004
8)眞部紀明,藤田 譲,綾木麻紀,他:除菌療法時代になって十二指腸潰瘍の治療例数は減ったのか? 消内視鏡32:1018-1020,2020
9)日本消化器病学会(編);消化性潰瘍診療ガイドライン2020,改訂第3版.南江堂,2020,p 61
10)関口久美子,萩原信敏,松谷 毅,他:内視鏡治療にて再手術を回避できた十二指腸潰瘍穿孔術後の1例.Prog Dig Endosc 82:154-155,2014
11)Koyama Y, Hayashi T, Fujita N, et al:Nonoperative treatment of reperforated duodenal ulcer:report of three cases. Surg Today 30:1034-1036, 2000
12)日下部光彦,松尾 篤,遠藤 郁,他:腹腔鏡を用いた十二指腸穿孔手術の7例—特に再穿孔例について.外科62:224-228,2000
13)三方彰喜,岩瀬和裕,桧垣 淳,他:十二指腸潰瘍再穿孔に対する腹腔鏡下大網充塡術の1例.日消外会誌36:96-99,2003
14)森眞二郎,大塚裕之,宇津秀晃,他:大網被覆術後に再穿孔を来した十二指腸潰瘍の1例.九州救急医誌10:20-24,2011
15)田中裕美子,石黒保直,丸山博行,他:固有肝動脈に穿通し出血性ショックを来した十二指腸潰瘍穿孔術後再発の稀な1例.臨と研95:1388-1391,2018
16)日本消化器病学会(編);消化性潰瘍診療ガイドライン2020,改訂第3版.南江堂,2020,p 36
17)Miwa H, Uedo N, Watari J, et al:Randomised clinical trial:efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers- results from two phase 3, non-inferiority randomised controlled trials. Aliment Pharmacol Ther 45:240-252, 2017